Australia launches new clinical trials website for consumers and it’s not as good as the UK’s (UKCTG)

We do beat ourselves up on a regular basis in this country.  Sometimes appropriately.  But often the punches fly a little too freely. Australia have launched a new clinical trials website today to boost patient recruitment.  It has strengths.  But it is not as good as our own UK Clinical Trials Gateway (UKCTG).  For one … Continue reading Australia launches new clinical trials website for consumers and it’s not as good as the UK’s (UKCTG)

GSK’s Witty remarks are easy to swallow from a patient perspective but the rest of the flock must follow

I spoke at the Clinical Discovery 2012 conference yesterday about the future value and impact of clinical research.  This is one of a number of similar events I've presented at over the last month or so.  On reflection there generally seems a more 'upbeat' conversation among conference-goers about clinical research in the UK compared to this time last … Continue reading GSK’s Witty remarks are easy to swallow from a patient perspective but the rest of the flock must follow

Clinical trials and children: impact on outcomes

Interesting paper from the Annals of Oncology and covered in PharmaTimes on how access to clinical trials has led to better outcomes for children with cancer.  The data relates to clinical trial activity promoted by the Children's Cancer and Leukaemia Group.  A direct quote from the article says: "Between 1966 and 1970 just 28% of young … Continue reading Clinical trials and children: impact on outcomes

There is no point to the javelin

It has come to this.  The world's top tennis players rush their shots to beat an 11pm curfew.  Bruce and Sir Paul are turned-off mid-performance.  And they don't use real javelins in schools. Looking across the the athletics field at my sons' school sports day, I spied a clutch of children competing in the javelin.  Except this … Continue reading There is no point to the javelin

The NHS Commissioning Board Draft Mandate and patients in health research

The Shard went up (officially).  And the NHS Commissioning Board Draft Mandate came down from on high.  All on the same day.  Add the odd torrential downpour with its associated misery and these could be Biblical times. I have come to the conclusion that it is my fate to be locked away somewhere remote and with an intermittent … Continue reading The NHS Commissioning Board Draft Mandate and patients in health research

PLoS ONE study – I’d go further: poor quality information undermines rights of clinical trial participants

On my recent visit to Newcastle, my afternoon was spent talking to, and answering questions from, the public about research.  Clinical trials featured heavily.  The most common theme was their frustration over the poor quality information given to trial participants before, during and after a trial had finished. The journal, PloS ONE, has today published a … Continue reading PLoS ONE study – I’d go further: poor quality information undermines rights of clinical trial participants

Pfizer undaunted by social media hurdles in clinical trial recruitment

This was reported last week in the US press but I have not seen it covered here in the UK. Pfizer has reeled-in its social media strategy for recruiting patients to a US clinical trial of over-active bladder drug, Detrol.  But it hopes to come back next year with a renewed 'virtual trial strategy.' In the meantime … Continue reading Pfizer undaunted by social media hurdles in clinical trial recruitment

Survey raises questions over NHS research

So it was an early start for me today, doing radio interviews for International Clinical Trials Day today.  I'll post the links to one or two when available.  Here's the press release from NIHR CRN which was the news peg for the interviews. NEWS RELEASE TEXT (HEADLINE AS ABOVE) The results of a new survey, published on … Continue reading Survey raises questions over NHS research

DH and charities reach acoRD over medical research costs

Divvying up the costs of conducting research in the NHS funded by medical research charities is an intricate business.   Who pays for that research nurse, their time in administering the extra treatment required in a clinical trial, the procedures and equipment needed as part of its conduct, the oversight and governance needed to ensure that things are done … Continue reading DH and charities reach acoRD over medical research costs

How evidence empowers consumers…from the Cochrane Collaboration

The Cochrane Collaboration has just launched a new website which explains how systematic reviews work, and the ways in which consumers can use the Cochrane reviews to inform decisions about their own health. Entitled 'YourHealthNet' there are some very honest and candid appraisals of the usefulness of Cochrane reviews, how the evidence can be both empowering but also … Continue reading How evidence empowers consumers…from the Cochrane Collaboration

Help set the agenda in cancer research….

The National Cancer Research Institute (NCRI) is on a recruitment drive for consumers (patients, carers, relatives and members of the public affected by cancer) to join one of their Clinical Studies Groups (CSGs). These Groups are pivotal in driving new ideas and setting the agenda for cancer research so a patient voice is essential.  There are ten … Continue reading Help set the agenda in cancer research….

Regulators push openness agenda on raw trial data…and EUPATI issues call for examples of educational materials on medicines development

Yes, that is a long headline is it not?  PharmaTimes and others cover a paper in PloS Medicine authored by a number of medicines regulators including the European Medicines Agency (EMA), calling for openness in raw trial data. The three pronged approach they suggest looks like a good basis for discussion.  It would be interesting … Continue reading Regulators push openness agenda on raw trial data…and EUPATI issues call for examples of educational materials on medicines development

“I thought, if nothing else comes out of this, I might be of service to other people” – ‘The Big C,’ NPR and clinical trials talk

Image via WikipediaTo begin with, this blog was going to be about the portrayal of clinical trials in popular drama,  inspired by the current US show 'The Big C.' The latest episode runs on More4 tonight at 10pm.  If you haven't seen it, then I strongly recommend a viewing. It is well-written, honest - to the point of sassy at … Continue reading “I thought, if nothing else comes out of this, I might be of service to other people” – ‘The Big C,’ NPR and clinical trials talk

Ill-informed consent: EU meeting lays into clinical trials small print for patients

Image by erjkprunczyk via FlickrDaniel Cressey at Nature has written this report from last week's meeting of the European Forum for Good Clinical Practice which took place in Brussels. The basic thrust of the discussion at the meeting was that information given to patients prior to them signing up for a clinical trial: is often vague, too long, … Continue reading Ill-informed consent: EU meeting lays into clinical trials small print for patients

UK clinical trials units go up for review and registration

One of the many good things to come out of the establishment of the UK Clinical Research Collaboration (UKCRC) in the early noughties, is the registration of UK clinical trials units and the bringing together of these units into a network. Registration, which takes the form of an application and then review by an independent international panel … Continue reading UK clinical trials units go up for review and registration